Last edition
News about "Potency Assurance Strategy "
US FDA Issues Final Guidance on Potency Assurance for Cell and Gene Therapies
US FDA issues final guidance outlining a science- and risk-based strategy to ensure the potency and quality of cellular and gene therapy products.
Potency Assurance Strategy | 04/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members